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Gender differences in asthma have been observed with a preponderance of boys
affected before puberty and girls during and after puberty. The known influences
of the menstrual cycle on asthma support a role for female sex hormones on the
changing expression of asthma during adolescence. The purpose of this study was
to investigate obesity, the menstrual cycle and lung function in adolescent girls. One
hundred and three female high school girls (mean age: 15.9± ±0.8 yr) were enroll-
ed. The investigation was performed using a questionnaire that included history of
asthma, the menstrual cycle, other combined allergic disease and obesity. The skin
prick and pulmonary function test during menstruation period and non-menstruation
period. Analyses of these factors were compared. The forced expiratory volume in
one second (FEV1)/forced vital capacity (FVC) was significantly lower in the obese
group compared to the non-obese group (99.8± ±13.8 vs. 107.1± ±10.2, p=0.03).
The FEV1 was significantly lower in the girls during menstruation period than in the
girls who were not on menstruation (77.5± ±10.2 vs. 80.4± ±8.6, p=0.03). Our results
showed that changes of pulmonary function were related to menstrual cycle and
obesity in Korean adolescent girls. 
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INTRODUCTION
It is well known that the asthma incidence is greater in
boys during childhood and in girls during adolescence. There
is no explanation for the change in gender related atopic dis-
ease to date. However, hormonal differences and their changes
during adolescence have been considered to be contributing
factors. It is well known that some female asthmatic patients
experience aggravation of asthma symptoms during the pre-
menstrual or menstrual phase of their cycle. This has been
referred to as perimenstrual asthma (PMA). PMA has been
documented in 30% to 40% of asthmatic women. This form
of asthma can be severe and even life threatening with fatal
cases were often reported. Therefore, prevention and treat-
ment of PMA is of great interest. However, the underlying
mechanisms associated with asthma exacerbation during the
perimenstrual period and the related hormones have not been
described (1-4). 
Several reports have noted associations of body mass index
(BMI), asthma and lung function. Reports on the association
of early menarche and increasing body weight with asthma
suggest that hormonal changes influence the incidence and
severity of asthma. However, study findings are inconsistent
and the underlying pathophysiology remains unknown (5,
6). Few studies have addressed the possible factors that influ-
ence asthma and lung function in adolescent girls. There-
fore, in this study, we have explored the factors that influ-
ence lung function in adolescent girls focusing on the hor-
monal factors related to the menstrual cycle and obesity. 
MATERIALS AND METHODS
Subjects 
High school girls from Seoul, Korea were recruited for this
study. We visited one high school three times between May
and June of 2006. Enrolled 103 subjects who could cooper-
ate with lung function test on both the second and third visit
among 135 girls that completed a questionnaire on the first
visit. The mean age was 15.9±0.8 yr and the range was 15-
18 yr. 
Methods 
Questionnaire 
The subjects answered a detailed questionnaire regarding
symptoms. Information from physicians included the diag-
nosis of asthma, body weight and height for BMI, menstrual
cycle, age at menarche, change of body weight and height
after menarche for calculating change of BMI after menar-
che, aggravation of asthma symptoms during the perimen-
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strual period, present and past history of allergic disease, and
smoking habits (Table 1). 
Asthma: The subjects who had a positive answer to either,
‘‘Have you ever had been diagnosed with asthma?’’ or ‘‘Have
you ever had attacks of breathlessness at rest with wheezing?’’
were classified as asthmatics and the others with a negative
answer were considered non- asthmatics. 
BMI: BMI was calculated as body weight (kg)/height2 (m2).
We classified subjects into ≥25 (obesity), 23-24.9 (over-
weight), 18.5-22.9 (normal), <18.5 (underweight) accord-
ing to the criteria from the Korean Society for the Study of
Obesity. 
Menstrual cycle and age at menarche: We collected infor-
mation on the average number of days of the menstrual cycle
and menstrual periods, regularity and dysmenorrhea. We
defined early menarche as menarche at 11 yr or earlier. 
Increased BMI after menarche: For examine whether an
increased BMI after menarche influenced asthma or lung func-
tion we compared the current BMI with that at menarche. 
PMA: PMA was defined as a self-reported worsening of
asthma symptoms during the perimenstrual phase (6). The
subjects with a positive answer to the question of ‘‘Have you
ever had experienced aggravation of asthma symptoms before
or during menstruation period?’’ or ‘‘Have you ever had expe-
rienced attacks of breathlessness at rest with wheezing before
or during menstruation period?’’ were classified as the PMA
group.
Present and past history of other combined allergic disease:
We collected information on the present and past history of
atopic dermatitis, allergic rhinitis or urticaria. 
Smoking: Depending on the smoking history, subjects
were divided into 3 categories: current smokers, ex-smok-
ers, non-smokers. 
Sensitization to inhalant allergens 
The skin prick test included house dust mites (Dermato-
phagoides farinae; Df, Dermatophagoides pteronyssinus; Dp), As-
pergillus fumigatus, and dog hair; all subjects were tested on
the second visit. We used histamine (1 mg/mL) as a positive
control and normal saline as a negative control. The skin prick
test was performed by placing a drop of 4 extracts and 2 con-
trol solutions on the volar surface of the forearm after the area
was prepared with 75% ethanol and dried. The drops were
placed 2 cm or more apart to avoid a false positive reading.
A lancet was passed through the drop, inserted into the epi-
dermal surface, and then gently lifted upward. After 15-30
min a wheal diameter of ≥3 mm or larger than the hista-
mine control was considered a positive result (7).
Lung function test 
Lung function test was performed twice for each subject
during the second and third visit in order to analyze the
changes in lung function according to the menstrual cycle.
We used a portable micro-spirometer (Super Spiro, Micro
Medical Ltd., Kent, U.K.) and provided instructions prior
to the test. At each visit, whether subjects were menstruat-
ing was recorded. 
Statistical analysis 
Statistical analyses were performed with the SPSS software,
version 12.0 (SPSS Inc., Chicago, IL, U.S.A.). Univariate anal-
yses were conducted using the Student’s t-test to compare
the mean of lung function test results between each of the
groups. A paired t-test was used for comparison of the mean
of lung function test results during the perimenstrual phase
and non-perimenstrual phase of the menstrual cycle. The non-
Birth date : 
Height :   Weight :  
1. (1) Have you ever had been diagnosed with asthma? Yes  □ No  □
(2) Have you ever had attacks of breathlessness at rest with wheezing?  Yes  □ No  □
2. Are you in your menstrual period? Yes  □ No  □
3.  (1) What is the first date of your last menstrual period? (  )
(2) What is average number of days of the menstrual period? (  days)
(3) What is average number of days of your menstrual cycle? (  days)
(4) Do you have a regular menstrual cycle? Yes  □ No  □
(5) Do you have dysmenorrhea? Yes  □ No  □
4. When is your first menstruation? (  )
5. What was your height and weight at first menstruation?  Height :   Weight :  
6. (1) Have you ever had experienced aggravation of asthma symptoms before or during menstrual period? Yes  □ No  □
(2) Have you ever had experienced attacks of breathlessness at rest with wheezing before or during  Yes  □ No  □
menstrual period?
7. Do you have present symptoms or past history of other allergic disease? Past                          Present
(1) Atopic dermatitis                                                                                                                                             Yes  □ No  □ Yes  □ No  □
(2) Allergic rhinitis                                                                                                                                                 Yes  □ No  □ Yes  □ No  □
(3) Urticaria                                                                                                                                                           Yes  □ No  □ Yes  □ No  □
8. Are you smoker?                                                                                                    Current smoker  □ Ex-smoker  □ Non-smoker  □
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parametric Wilcoxon signed rank test was performed to ana-
lyze differences between the mean of lung function test results
during the perimenstrual phase and non-perimenstrual phase
of the menstrual cycle in the PMA group. pvalues <0.05 were
considered significant. 
RESULTS
Population characteristics 
The average age of the subjects was 15.9±0.8 (range 15-
18) and 49 (47.6%) had the diagnosis of asthma among the
103 subjects. The average of BMI was 20.5±2.9. The number
of underweight students (22.3%) is greater than obese stu-
dents (10.7%). There were 62.1% of subjects who were smok-
ers including current smokers (38/103, 36.9%) and ex-smok-
ers (26/103, 25.3%). The average age of menarche was 11.9
±1.1 and 32 (31.1%) girls had early menarche (<12 yr old).
The subjects answered questions on weight and height at the
time of menarche to evaluate an increase in BMI after menar-
che, however 34 among the 103 could not remember. Sixty-
two (78.5%) among 79 girls who did remember showed that
the present BMI was increased compared to at menarche.
Among the 49 asthmatics, 11 (22.5%) had symptoms of
perimenstrual asthma (Table 2). 
Comparison between the obesity group and the non-
obesity group 
Among the 11 subjects with BMI of 25 or more, there were
three (27.3%) with the diagnosis of asthma this was a small-
er percentage than the 46 (50%) among the 92 with BMI
less than 25. Four students (36.4%) had menarche at an age
less than 12 among 11 in the obese group and 28 (30.4%)
among 92 in the non-obese group. Six students (54.5%) were
sensitized to inhalant allergens among 11 in the obese group.
This was a two fold higher compared to the 21 (22.8%) out
of 92 in the non-obese group.
Comparison between the asthmatics and the 
non-asthmatics 
There were 3 (6.1%) obese students with BMI of 25 or
more among the 49 subjects with the diagnosis of asthma;
this was less than the 8 (14.8%) among the 54 non-asthmat-
ics. The numbers of the girls with early menarche (<12 yr
old) was similar in asthmatics and non-asthmatics (30.6%
and 31.5%). The students who had an increase of their BMI
after menarche were 59.2% in asthmatics and 61.1% in non-
asthmatics. 
The smokers was 65.3% in asthmatics and 59.3% in non-
asthmatics. The number of the students who were sensitized
to inhalant allergens was similar in asthmatics and non-asth-
matics (26.5% in asthmatics and 25.9% in non-asthmat-
ics). The students who had atopic dermatitis, allergic rhini-
tis or urticaria in their history were more common in the
asthma group (51% in asthmatics and 38.9% in non-asth-
matics) and 53.1% students with atopic disease currently
had asthma and 27.8% in non-asthmatics.
Lung function test 
Obesity and lung function test 
The average percent of predicted forced expiratory volume
in one second (FEV1), forced vital capacity (FVC), FEV1/FVC,
*, kg/m
2; 
� , Seventy nine girls of total 103 could remember body weight
and height at her menarche; 
� , Atopic dermatitis, allergic rhinitis or urticaria.
BMI, body mass index.
Characteristics Mean±SD or N (%)
Age (yr) 15.9±0.8 
Asthmatics 49 (47.6)
BMI* 20.5±2.9
Underweight (-18.4) 23 (22.3)
Normal (18.5-22.9) 59 (57.3)
Overweight (23-24.9) 10 (9.6)
Obesity (25-) 11 (10.7)
Current smoker 38 (36.9)
Ex-smoker 26 (25.2)
Age at menarche (yr) 11.9±1.1
Early menarche (<12 yr old) 32 (31.1)
Irregular cycles 62 (60.2)
Dysmenorrhea 60 (58.3)
Interval of menstrual cycle (days) 28.9±4.1 (17-45)
Duration of menstrual cycle (days) 5.7±1.4 (3-8.5)
Increased BMI after menarche 62/79
�(78.5)
Perimenstrual asthma (% of asthma) 11/49 (22.5)
Past history of allergic disease
� 46 (44.7)
Present history of allergic disease
� 41 (39.8)
Aeroallergen sensitization 27 (26.2)
Pulmonary function test
FEV1, %predicted 77.2±9.7
FVC, %predicted  76.1±11.3
FEV1/FVC 106.3±10.8
FEF25-75%, %predicted 72.7±17.8
Table 2. Characteristics of 103 adolescent girls
*, Statistical significances were evaluated by student t-test.
BMI, body mass index.
Obesity
BMI ≥25 BMI <25
p
value*
FEV1, % predicted 75.9±12.1 77.3±9.4 0.65
FVC, % predicted 79.5±13.6 75.6±11.0 0.29
FEV1/FVC 99.8±13.8 107.1±10.2 0.03
FEF25-75%, % predicted 64.6±18.1 73.7±17.6 0.10
Table 3. Pulmonary function tests in adolescent girls associa-
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and forced expiratory flow from 25 to 75% of the vital capac-
ity (FEF25-75%) in the group with BMI of 25 or more com-
pared to the group with BMI less than 25 were the follow-
ing: 75.9±12.1 vs. 77.3±9.4 (p=0.65), 79.5±13.6 vs.
75.6±11.0 (p=0.30), 99.8±13.8 vs. 107.1±10.2 (p=0.03),
64.6±18.1 vs. 73.7±17.6 (p=0.10). The mean percent of
predicted FEV1/FVC was significantly different in the com-
parison between these two groups (Table 3).
Smoking and lung function test 
The average percent of predicted FEV1, FEV1/FVC, FVC,
and FEF25-75% in smokers compared to non-smokers were
76.1±9.3 vs. 78.9±10.1 (p=0.16), 74.4±11.2 vs. 78.8
±11.0 (p=0.06), 107.5±10.1 vs. 104.3±11.6 (p=0.15),
73.0±17.4 vs. 72.3±18.7 (p=0.84).
Other allergic diseases and lung function test 
The average percent of predicted FEV1, FEV1/FVC, FVC,
and FEF25-75% in the group with other allergic disorders (ato-
pic dermatitis, allergic rhinitis or urticaria) compared to the
group without allergic disease were 77.8±10.1 vs. 76.8±
9.4 (p=0.63), 78.5±12.0 vs. 74.5±10.6 (p=0.08), 103.3
±11.5 vs. 108.2±9.9 (p=0.03), 69.6±18.4 vs. 74.8±
17.3 (p=0.15). The average percent of predicted FEV1/FVC
was significantly different in comparisons between these two
groups.
Allergen sensitization and lung function test 
The average percent of predicted FEV1, FEV1/FVC, FVC,
and FEF25-75% in the group sensitized to inhalant allergens
(positive skin prick test to house dust mites (Df and Dp), A.
fumigatus, or dog hair) compared to those without sensitiza-
tion was 76.0±9.4 vs. 79.9±10.8 (p=0.08), 74.6±10.1
vs. 79.9±13.7 (p=0.04), 104.6±12.8 vs. 106.7±10.5 (p=
0.40), 71.9±18.8 vs. 74.2±17.1 (p=0.59). The average
percent of predicted FEV1/FVC was significantly different
in the comparisons between these two groups. 
Lung function according to menstrual cycle 
Lung function tests were performed twice in each subject
at two-week intervals. The students who could be tested dur-
ing both the menstrual phase and non-menstrual phase were
51 among the total group of 103. The average percent of pre-
dicted FEV1, FEV1/FVC, FVC, and FEF25-75% during men-
struation compared to the non-menstruating phase were 77.5
±10.2 vs. 80.4±8.6 (p=0.03), 76.8±9.5 vs. 77.2±9.5
(p=0.72), 105.8±11.7 vs. 108.4±8.0 (p=0.05), 72.7±18.1
vs. 76.5±16.0 (p=0.09). The average percent of predicted
FEV1 was significantly different in the comparisons between
these two groups (Table 4). Among 11 students who report-
ed symptoms of perimenstrual asthma, 6 could be tested both
during menstruation and during the non-menstrual phase.
Comparison of their lung function during the menstrual
phase and non-menstrual phase showed that FEV1/FVC and
the average percent of predicted FEF25-75% were significantly
lower during the menstrual phase (p=0.03) (Table 5).
DISCUSSION
The prevalence of obesity in this study group was 10.7%
similar to the prevalence of 10.2% previously reported in
Korean girls in 2005 by Kim (8). Kim et al. reported that
in comparison to the data reported in 1998, body weight
and BMI in all ages of girls under 20 yr increased with the
exception of girls over 19 who showed a trend towards reduced
BMI; suggesting a recent social trend toward undue value
of body shape among young people (8, 9). In this study, under-
weight girls accounted for 22.3% of the subjects, more than
twice the number of obese girls. 
There are several reports that found an increase in BMI to
be associated with an increase in the prevalence of asthma
especially in women (11-15). Chang et al. (16) found obesi-
ty (BMI ≥25) to be a risk factor for asthma in Korean wo-
men. In this study the girls who were diagnosed with asth-
ma, or reported symptoms of asthma, were less prevalent in
the obese group (BMI ≥25) than in the non-obese group
and the obese girls were less common among the asthmatics
compared to the non-asthmatics. However, the results of the
lung function test showed that the FEV1/FVC in the obese
group was significantly lower than in the non-obese group.
These findings are consistent with the report by Hancox (11)
who found a significant inverse association between BMI and
FEV1/FVC in females. Several mechanisms can explain why
obesity is a risk factor for asthma. First, obesity may affect
*, Statistical significances were evaluated by student t-test.
Menstrual 
period
Non-menstrual 
period
p
value*
FEV1, % predicted 77.5±10.2 80.4±8.6 0.03
FVC, % predicted 76.8±9.5 77.2±9.5 0.72
FEV1/FVC 105.8±11.7 108.4±8.0 0.05
FEF25-75%, % predicted 72.7±18.1 76.5±16.0 0.09
Table 4. Changes of pulmonary function test results according
to menstrual cycle (N=51) in 103 adolescent girls
*, Statistical significances were evaluated by Wilcoxon signed rank test.
Menstrual 
period
Non-menstrual 
period
p
value*
FEV1, % predicted 73.8±10.8 78.7±10.8 0.11
FVC, % predicted 80.0±8.1 77.7±13.5 0.50
FEV1/FVC 94.8±7.9 105.8±10.5 0.03
FEF25-75%, % predicted 56.3±12.1 67.2±12.9 0.03
Table 5. Results of pulmonary function test in 6 patients with a
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asthma directly by causing decreased tidal excursion leading
to smooth muscle latching, and indirectly by enhancement
of gastro-esophageal reflux. Second, ‘‘leptin’’, a proteohor-
mone produced by adipocytes, which shows a positive cor-
relation with BMI, has receptors in human lung tissue and
provides a link between inflammation and T-cell function
in asthma (12, 13). One reason for a stronger relationship
between BMI and asthma prevalence in women compared
to men and children before puberty may be that women have
more body fat mass compared to men with the same BMI
and this is related to estrogen (14, 15). Hancox (11) and Weiss
(15) reported that BMI and atopy were correlated. In our
study, we found sensitization to inhalant allergens to be twice
as common in the obese group compared to the non-obese
group. 
In addition, we found that smokers accounted for 62.1%
of asthmatics more than the non-asthmatics. Several studies
have reported that smoking is a risk factor for asthma, atopy
and bronchial hyper-responsiveness and that it contributes
to an increase in the incidence of asthma in women. Further-
more, smoking causes a more severe decline in lung func-
tion in asthmatics (17, 18). Our findings showed that the
FEV1 and FVC were lower in smokers than in non-smokers
but the differences were not statistically significant (p=0.16,
p=0.06). 
The average age of menarche was found to be 12.6±0.9
in 15 yr olds in Ansan city, in 2001 (19). In this study, it
was lower, 11.9±1.1. Salam (20) reported that women with
menarche before age 12 had a 2.08-fold higher risk of asth-
ma after puberty, and suggested that this is related to the sex
hormones; estrogen and progesterone. One report found that
an increased BMI in young female adults contributed to a new
diagnosis of asthma (18). In our study, an early menarche or
a raised BMI after menarche had no association with asthma.
However, our study findings are based on a self-reported ques-
tionnaire. The results may be different if we could determine
more accurately the onset of asthma and evaluate subjects
over a longer time. Allergic disease such as atopic dermati-
tis, allergic rhinitis and urticaria were more common in the
asthmatics than in the non-asthmatics and the FEV1/FVC
was significantly lower in the group with allergic disease than
in the group without allergic disease. We found that the ratio
of sensitization to inhalant allergen was 26.2% and this was
a little higher in asthmatics. Sensitization to inhalant aller-
gens has a strong correlation with asthma, allergic rhinitis
and bronchial hyper-responsiveness it contributes to an increase
in asthma severity and a decrease in lung function (21-24).
We found that the FVC was significantly lower in the group
with sensitization to inhalant allergens. 
Studies suggest that 30 to 40% of asthmatic women report
significant exacerbation of asthma symptoms, increase in
inhaled short acting beta 2-agonist use or decrease in morn-
ing peak flow rate during the perimenstrual phase (25, 26).
Furthermore, the asthma attacks related to menstruation are
more severe and may be fatal. There are concerns that PMA
may be increasing (27, 28). However, the underlying mech-
anism of PMA remains unclear. There are several hypothe-
ses on the cause of PMA. First, the role of sex hormones on
bronchial smooth muscle and β 2-adrenergic receptor func-
tion. Progesterone potentiates the relaxation effect of β 2-ago-
nists on bronchial smooth muscle in vitro. The expected in-
crease in sex-steroid hormones, in non-asthmatic female pa-
tients during the luteal phase of the menstrual cycle, is fol-
lowed by an increase in lymphocyte β 2-adrenergic receptor
density. However, this regulatory function appears to be lost
in women with asthma, who instead appear to show a down
regulation of β 2-adrenergic receptor density when exposed to
progesterone. Second, female sex hormones have effects on
several cells and cytokines involved in inflammation. Periph-
eral blood total white blood cell counts are increased, and a
marked deviation of the TH1/TH2 balance toward TH2 occurs
during the luteal phase of menstruation. Third, fluid reten-
tion is another possible pathophysiologic factor associated
with PMA. Increased perimenstrual hydration gives rise to
swelling of subcutaneous tissue of the extremities and other
parts of the body, such as the bronchial mucosa. This might
lead to edema and airway narrowing. In addition, it has been
suggested that prostaglandins related to estrogen levels have
a role in PMA. Moreover, it has been suggested that proges-
terone enhances hyperventilation and psychological factors
during the premenstrual period and influence respiratory
symptoms (6, 28, 29). 
PMA is defined as an increase in asthma symptoms or a
decrease in lung function during the perimenstrual phase.
There is one report that there were significantly more near
fatal asthma episodes on the first day of menstruation (28).
However, another study reported that emergency room visits
for acute asthma were most common during the preovulato-
ry phase (from 5th day to 11th day) (29). When we planed
this study, we intended to determine the exact day of the men-
strual cycle at the time of lung function test, but a large num-
ber of subjects had irregular menstrual cycles and several stu-
dents could not remember the first day of their last menstru-
al phase. Therefore, we could compare lung function test only
divided by the menstrual phase and the non-menstrual phase.
We found that the FEV1 during the menstrual phase was
lower than the non-menstrual phase and this difference was
statistically significant. Furthermore, FEV1/FVC during the
menstrual phase compared to the non-menstrual phase was
found to show a very large difference. Moreover, in the group
that reported symptoms of perimenstrual asthma, FEV1/FVC
and FEF25-75% were significantly lower during the menstrual
phase. These findings suggest a correlation between the men-
strual cycle and lung function in Korean adolescent girls.
Therefore, it may be important to take into consideration
hormonal changes related to the menstrual cycle when treat-
ing asthmatic adolescent girls. 
There is limited information on the association of asthma,Obesity, the Menstrual Cycle and Lung Function in Korean Adolescent Girls 25
lung function and puberty. Our findings provide initial basic
data in Korean high school girls. Our results showed that air-
flow limitation was present in the obese group, in girls with
allergic disorders and during the menstrual phase as well as
in girls who were sensitized to inhalant allergens. Further
investigation into the relationship of sex hormones, leptin,
lung function and asthma is needed in adolescent girls. 
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